journal article·2014-01Open access

Occupational safety and health criteria for responsible development of nanotechnology

P. A. Schulte, C. L. Geraci, V. Murashov, E. D. Kuempel, R. D. Zumwalde, V. Castranova, M. D. Hoover, L. Hodson, K. F. Martinez

Journal of Nanoparticle Research· Volume 16· Issue 1

Abstract

Organizations around the world have called for the responsible development of nanotechnology. The goals of this approach are to emphasize the importance of considering and controlling the potential adverse impacts of nanotechnology in order to develop its capabilities and benefits. A primary area of concern is the potential adverse impact on workers, since they are the first people in society who are exposed to the potential hazards of nanotechnology. Occupational safety and health criteria for defining what constitutes responsible development of nanotechnology are needed. This article presents five criterion actions that should be practiced by decision-makers at the business and societal levels-if nanotechnology is to be developed responsibly. These include (1) anticipate, identify, and track potentially hazardous nanomaterials in the workplace; (2) assess workers' exposures to nanomaterials; (3) assess and communicate hazards and risks to workers; (4) manage occupational safety and health risks; and (5) foster the safe development of nanotechnology and realization of its societal and commercial benefits. All these criteria are necessary for responsible development to occur. Since it is early in the commercialization of nanotechnology, there are still many unknowns and concerns about nanomaterials. Therefore, it is prudent to treat them as potentially hazardous until sufficient toxicology, and exposure data are gathered for nanomaterial-specific hazard and risk assessments. In this emergent period, it is necessary to be clear about the extent of uncertainty and the need for prudent actions.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Air Quality and Health Impacts · Chemical Safety and Risk Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. 78 Federal Register 36784 (2013) Survey of nanomaterial risk management practices. Centers for Disease Control and Prevention, Cincinnati
2. Aitken RJ, Creely KS, Tran CL (2004) Nanoparticles: an occupational hygiene review. Institute of Occupational Medicine, Edinburgh
3. Alloff E, Lin P (eds) (2008) Nanotechnology and society: current and emerging ethical issues. Springer, New York
4. American Textile Manufacturers Institute Inc. et al. versus Donovan 452 US 490 (1981) available at http://supreme.justia.com/cases/federal/us/452/490/case.html . Accessed 3 Dec 2013
5. ANSES (2010) Development of a specific control banding tool for nanomaterials. French Agency for Food, Environmental and Occupational Health and Safety. No 2008-SA-0407, Córdoba
6. Antonini JM (2003) Health effects of welding. Crit Rev Toxicol 33(1):61–10310.1080/713611032 ↗
7. Ashford NA (1976) Crisis in the workplace: occupational disease and injury. MIT Press, Cambridge
8. BASF (2013) Nanotechnology code of conduct. http://www.basf.com/group/corporate/en/about-basf/strategy/purpose-principles-values/code-of-conduct/index . Accessed 16 Aug 2013
9. BAuA (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin) (2007) Guidance for handling and use of nanomaterials at the workplace. http://www.baua.de/en/Topics-from-A-to-Z/Hazardous-Substances/Nanotechnology/pdf/guidance.pdf?__blob=publicationFile&v=2 . Accessed 16 Aug 2013
10. Bauer MW (2009) The evolution of public understanding of science-discourse and comparative evidence. Sci Technol Soc 14:221–24010.1177/097172180901400202 ↗
11. Bayer Material Science (2010) Occupational exposure limit (OEL) for baytubes defined by Bayer material science. http://www.baytubes.com/news_and_services/news_09116_oel.html . Accessed 16 Aug 2013
12. Beaudrie CE, Kandlikar M, Satterfield T (2013) From cradle-to-grave at the nanoscale: gaps in US regulatory oversight along the nanomaterial life cycle. Environ Sci Technol 47:5524–553410.1021/es303591x ↗
13. Berube DM (2006) Nano-hype: the truth behind the nanotechnology buzz. Prometheus Books, Amherst
14. Berube DM, Fabee B, Scheafela DA, Cummings CL, Barduer GE, Martin MS, Temple NM (2010) Communicating risk in the 21st century: the case of nanotechnology. An independent analysis commissioned by the NNCO, Arlington. http://www.nano.gw/sites/default/files/pub_resource/berube-risk-white-paper-feb-2010.pdf . Accessed 16 Aug 2013
15. Bonner JC, Solva RM, Taylor AJ, Brown JM, Hilderbrand SC, Castranova V et al (2013) Inter laboratory evaluation of rodent pulmonary response to engineered nanoparticles. Environ Health Perspect 121:676–68210.1289/ehp.1205693 ↗
16. Boutou-Kempf O, Marchand J-L, Radauceanu A, Witschger O, Imbernon E, Health Risks of Nanotechnologies Group (2011) Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace. J Occup Environ Med 53(6):S103–S10710.1097/JOM.0b013e31821b1d68 ↗
17. Brouwer DH (2012) Control banding approaches for nanomaterials. Ann Occup Hyg 56(5):506–514
18. Brouwer D, Berges M, Virgi M, Fransman W, Bello D, Hodson L, Gabriel S, Tielsmans E (2012) Harmonization of measurement strategies for exposure to manufractured nano-objects; report of a workshop. Ann Occup Hyg 56910:1–910.1093/annhyg/mer099 ↗
19. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K (2001) Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175(3):191–19910.1006/taap.2001.9240 ↗
20. BSI (2007) Nanotechnologies, part 2: guide to safe handling and disposal of manufactured nanomaterials. British Standards Institution, London, p 6699
21. Business Industrial Advisory Committee to the OECD (BIAC) (2013) Responsible development of nanotechnology turning vision into reality. http://www.biac.org/news/2013/1303_BIAC_Vision_Paper_on_Nanotechnology.htm . Accessed 26 Jul 2013
22. CalOSHA (2013) Worker responsibilities. http://www.dir.ca.gov/dosh/workersrResponsibilities.htm . Accessed 16 Aug 2013
23. Canadian Standards Association (2012) Nanotechnologies—exposure control program for engineered nanomaterials in occupational settings. CSA Z-12885-12. Canadian Standards Association, Toronto
24. CEST (Commission de l’ Ethique de la Science et de la Technologie) (2008) Ethics, risk, and nanotechnology: responsible approaches dealing with risk. In: Allhoff F, Lin P (eds) Nanotechnology and Society. Springer, DV, pp 75–89
25. Clark KA, White RH, Silbergeld EK (2011) Predictive models for nanotoxicology: current challenges and future opportunities. Regul Toxicol Pharmacol 59:361–36310.1016/j.yrtph.2011.02.002 ↗
26. Colvin V (2002) Responsible nanotechnology logic: looking beyond the good news. http://www.eurekalert.org/context.php?context=nano&show=essays&essaydate=1102 . Accessed 26 Jul 2013
27. Cook WA (1945) Maximum allowable concentrations of industrial contaminants. Ind Med 14:936–946
28. Dahm MM, Evans DE, Schubauer-Berigan MK, Birch ME, Fernback JE (2012) Occupational exposure assessment in carbon nanotube and nanofiber primary and secondary manufacturers: mobile direct-reading sampling. An Occup Hyg 56(5):542–556. doi: 10.1093/annhyg/mer110
29. Dankovic D, Kuempel ED, Wheeler M (2007) An approach to risk assessment for TiO2. Inhal Toxicol 19:205–21210.1080/08958370701497754 ↗
30. Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE (1993) An association between air pollution and mortality in six US cities. N Engl J Med 329(24):1753–175910.1056/NEJM199312093292401 ↗
31. Dressen WC, Dallavale JM, Edwards JI, Miller JW, Sayers RR (1938) A study of asbestosis in the asbestos textile industry. US Treasury Department, Public Health Bulletin No. 241, Government Printing Office, Washington
32. Driscoll KE (1996) Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. Inhal Toxicol 8:139–154
33. Duffin R, Tran CL, Clouter A (2002) The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Ann Occup Hyg 46(Suppl 1):242–24510.1093/annhyg/46.suppl_1.242 ↗
34. Eastlake A, Hodson L, Geraci CL, Crawford C (2012) A critical evaluation of material safety data sheets (MSDS) for engineered nanomaterials. J Chem Health Safety 19(5):1–810.1016/j.jchas.2012.02.002 ↗
35. Engeman CD, Baumgartner L, Carr BM et al (2012) Governance implications of nanomaterials companies inconsistent risk perceptions and safety practices. J Nanopart Res 14:749–76110.1007/s11051-012-0749-0 ↗
36. EPA (2013) Significant new use rules on certain chemical substances. 40 CFR Parts 9 and 721. RIN 2070-AB27. Direct Rule. Federal Register Vol 78, Issue 152 (August 7, 2013)
37. EU–OSHA (2002) Workplace exposure to nanoparticles. European Agency for Safety and Health at Work, Bilbao
38. European Commission (2005) Nanosciences and nanotechnologies: an action plan for Europe 2005–2009. COM, Brussels, p 243
39. Falkner R, Jaspers N (2012) Regulating nanotechnologies: risk, uncertainty and the global governance gap. Global Environ Polit 12(1):3010.1162/GLEP_a_00096 ↗
40. Forloni G (2012) Responsible nanotechnology development. J Nanopart Res 14:100710.1007/s11051-012-1007-1 ↗
41. Gardiner K, van Tongeren M, Harrington M (2001) Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry. Occup Environ Med 58:496–50310.1136/oem.58.8.496 ↗
42. Gewirth A (1986) Human-rights and the workplace. Am J Ind Med 9(1):31–4010.1002/ajim.4700090107 ↗
43. Gibson R, Stacey N, Drais E, Wallin H, Zatorski W, Virpi V (2012) Risk perception and risk communication with regard to nanomaterials in the workplace. European Agency for Safety and Health at Work, Luxembourg
44. Hansen SF, Maynard A, Baun A, Tickner JA (2008) Late lessons from early warnings for nanotechnology. Nature Nanotechnol 3:444–44710.1038/nnano.2008.198 ↗
45. Harthorn BH (2006) Nano-buzz: societal dimensions of emerging technologies. Anthropol News 47(7):2610.1525/an.2006.47.7.26 ↗
46. Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch W, Levsen K (1995) Chronic inhalation exposure of wistar rats and 2 different strains of mice to diesel-engine exhaust, carbon-black, and titanium-dioxide. Inhal Toxicol 7(4):533–55610.3109/08958379509015211 ↗
47. Hett A (2004) Nanotechnology: small matter, many unknowns. Zurich-Swiss Reinsurance Company, Zurich
48. Higgins E et al (1917) Siliceous dust in relation to pulmonary diseases among miners in the Joplin district, Missouri. Bulletin 132. US Department of Interior, Bureau of Mines, Washington
49. Hinds WC (1999) Aerosol technology, 2nd edn. Wiley, New York
50. Howard J (2011) Dynamic oversight: implementation gaps and challenges. J Nanopart Res 13:1427–143410.1007/s11051-011-0225-2 ↗
51. HSA (Health and Safety Authority) (2005) Safety, health and welfare act. HSA, London
52. HSE (2004) Nanotechnology. Horizons scanning information note no. HSIN1. Health and Safety Executive, London
53. HSE (2013) Your health, your safety: a brief guide for workers. HSE, London. http://www.hse.gov.uk/pubns/indg450.htm . Accessed 16 Aug 2013
54. ILO (2008) Seoul Declaration on Safety and Health at Work (2008). www.seouldeclaration.org . Accessed 16 Aug 2013
55. Interessengemieinschaft Detailhandel Schweiz (IG-DHS) (2013) Code of conduct for nanotechnologies. http://www.innovationsgesellschaft.ch/media/archive2/publikationen/CoC_Nanotechnologies_english.pdf . Accessed 17 Jan 2013
56. International Council on Nanotechnology (ICON) (2006) A review of current practices in the nanotechnology industry. Phase two report: survey of current practices in the nanotechnology workplace. University of California Santa Barbara, Santa Barbara
57. Invernizzi N (2011) Nanotechnology between the lab and the shop floor: what are the effects on labor? J Nanopart Res 13:2249–2268. doi: 10.1007/s11051-011-0333-z10.1007/s11051-011-0333-z ↗
58. IOM (2000) Development of a biomathematical lung model to describe the exposure-dose relationship for inhaled dust among UK coal miners. In: Tran CL (ed) IOM Research Report TM/00/02. B.D., Institute of Occupational Medicine, Edinburgh
59. ISO (2007) Workplace atmospheres. Ultrafine nanoparticle and nano-structured aerosols: inhalation, exposure characterization and assessment. International Organization for Standardization, ISO/TR, Geneva, p 27628
60. ISO (2009) Guide to safe handling and disposal of manufactured nanomaterials, Draft report. ISO/TC 229 Nanotechnologies working group 3: health, safety and the environment, project group 6. International Organization for Standardization, Seattle
61. Jacobstein N (2006) Foresight guidelines for responsible nanotechnology development. https://www.foresight.org/guidelines/ForesightGuidelinesV6.pdf . Accessed 16 Aug 2013
62. Jones RM, Nicas M (2006) Margins of safety provided by COSHH essentials and the ILO chemical control toolkit. Ann Occup Hyg 50(2):149–15610.1093/annhyg/mei054 ↗
63. Jonsen AR (1991) Ethical considerations and responsibilities when communicating health risk information. J Clin Epidemiol 44:69–7210.1016/0895-4356(91)90178-C ↗
64. Karn B, Bergeson L (2009) Green nanotechnology: straddling promise and uncertainty. American Bar Association, Natural Resource & Environment, Fall 2009, Vol. 24, Issue 2
65. Kreider T, Halperin W (2011) Engineered nanomaterials: learning from the past, planning for the future. J Occup Environ Med 53(6):S108–S11210.1097/JOM.0b013e31821b146a ↗
66. Kuempel ED, Tran CL, Castranova V, Bailer AJ (2006) Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans. Inhal Toxicol 18(10):717–72410.1080/08958370600747887 ↗
67. Kuempel ED, Geraci CL, Schulte PA (2012a) Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Ann Occup Hyg 56(5):491–505
68. Kuempel ED, Castranova V, Geraci CL, Schulte PA (2012b) Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res 14(9):102910.1007/s11051-012-1029-8 ↗
69. Kulinowski K, Lippy B (2012) Training workers on risks of nanotechnology. National Institutes of Health, National Institute of Environmental Health Sciences, Bethesda, p 43
70. Lee JH, Kuk WK, Kwon M, Lee JH, Lee KS, Yu IJ (2012) Evaluation of information in nanomaterial safety data sheets and development of international standards for guidance on preparation of nanomaterial safety data sheets. Nanotoxicology 7(3):338–34510.3109/17435390.2012.658095 ↗
71. Li N, Nel AE (2011) Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research? J Occup Environ Med 53(6):S74–S7910.1097/JOM.0b013e31821b1bf2 ↗
72. Ling M-P, Lin W-C, Liu CC, Huang Y-S, Chues M-J, Shih T-S (2012) Risk management strategy to increase the safety of workers in the nanomaterials industries. J Hazard Mater 229(230):83–9310.1016/j.jhazmat.2012.05.073 ↗
73. Liou S-H, Lin M-H, Hse C-H, Tsoou CJ, Li H-L, Li W-F, Lin P-P, Li L-A (2011) The pilot study of specific biomarkers in a health effects among engineered nanoparticle. Epidemiology 22:s254–s25510.1097/01.ede.0000392474.54980.cf ↗
74. Luigi F (2009) Responsible care and nanomaterials case study: Nanocyl. In: Proceedings of the European responsible care conference. http://www.cefic.org/Documents/ResponsibleCare/04_Nanocyl.pdf . Accessed 3 Dec 2013
75. Maiello ML, Hoover MD (eds) (2011) Radioactive air sampling methods. CRC Press, Boca Raton
76. Maynard AD (2006) Nanotechnology: assessing the risks. Nano Today 1(2):22–3310.1016/S1748-0132(06)70045-7 ↗
77. Maynard AD, Kuempel ED (2005) Airborne nanostructured particles and occupational health. J Nanopart Res 7(6):587–61410.1007/s11051-005-6770-9 ↗
78. McKinney W, Chen B, Frazer D (2009) Computer controlled multi-walled carbon nanotube inhalation exposure system. Inhal Toxicol 21(12):1053–106110.1080/08958370802712713 ↗
79. Merget R, Bauer T, Kupper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T (2002) Health hazards due to inhalation of amorphous silica. Arch Toxicol 75:625–63410.1007/s002040100266 ↗
80. Murashov V, Howard J (2008) The US must help set international standards for nanotechnology. Nat Nanotechnol 3(11):635–63610.1038/nnano.2008.323 ↗
81. Murashov V, Howard J (2013) Protecting nanotechnology workers while waiting for Godot. J Occup Environ Hyg 10(8):D116–D11710.1080/15459624.2013.803914 ↗
82. Murashov V, Schulte PA, Geraci C, Howard J (2011) Regulatory approaches to worker protection in nanotechnology industry in the USA and European Union. Ind Health 49(3):280–29610.2486/indhealth.MS1228 ↗
83. Murashov V, Schulte PA, Howard J (2012) Progression of occupational risk management with advances in nanomaterials. J Occup Environ Hyg 9(1):D12–D2210.1080/15459624.2012.638217 ↗
84. Nakanishi J (ed) (2011a) Risk assessment of manufactured nanomaterials: approaches. Overview of approaches and results. NEDO, Kawasaki City, Japan
85. Nakanishi J (ed) (2011b) Risk assessment of manufactured nanomaterials: carbon nanotubes (CNT). NEDO, Kawasaki City, Japan
86. Nano Risk Framework (2007) www.NanoriskFramework.com . Accessed 3 Dec 2013
87. Nanocyl (2009) Responsible care and nanomateials case study nanocyl. Presentation at European responsible care conference, Prague 21–23rd October, 2009. http://www.cefic.be/Files/Downloads/04_Nanocyl.pdf . Accessed 23 Apr 2010
88. Nanosafe (2008) Nanosafe2: Efficiency of fibrous filters and personal protective equipment against nanoaerosols. Paper presented at the Nanosafe 2008, 3–7 November 2008, Grenoble
89. National Academy of Engineering (2004). Emerging technologies and ethical issues in engineering: papers from a workshop, 14–15 October 2003. National Academies Press, Washington
90. Naumann BD, Sargent EV, Starkman BS, Fraser WJ, Becker GT, Kirk GD (1996) Performance-based exposure control limits for pharmaceutical active ingredients. Am Ind Hyg Assoc J 57(1):33–4210.1080/15428119691015197 ↗
91. Nel A, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H (2013) Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607–62110.1021/ar300022h ↗
92. NIOSH (2002) Hazard review: health effects of occupational exposure to respirable crystalline silica. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 129
93. NIOSH (2005) Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Draft report for public review, Cincinnati
94. NIOSH (2009a) Notification on precautionary measures for prevention of exposures to nanomaterials. Japan NIOSH Notification No. 0331013. Labour Standard Bureau, Ministry of Health, Labour and Welfare, Japan
95. NIOSH (2009b) Approaches to safe nanotechnology: managing the health and safety concerns associated with engineered nanomaterials. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 125
96. NIOSH (2009c) Qualitative risk characterization and management of occupational hazards: control banding (CB): a literature review and critical analysis. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 152
97. NIOSH (2009d) Current Intelligence Bulletin 60: Interim guidance for medical screening and hazard surveillance for workers potentially exposed to engineered nanoparticles. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 116
98. NIOSH (2011a) Current intelligence bulletin 64: coal mine dust exposures and associated Health outcomes: a review of information published since 1995. Occupational exposure to titanium dioxide. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati
99. NIOSH (2011b) Current intelligence bulletin 63. Occupational exposure to titanium dioxide. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 160
100. NIOSH (2013a) Current intelligence bulletin 65. Occupational exposure to carbon nanotubes and nanofibers. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH), Cincinnati, p 145